Ranee Mehra

16.5k citations
165 papers · 11k · 9 hit papers · h-index 39

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research

Papers in

Ranee Mehra

157 papers receiving 10.7k citations

Ranee Mehra's Hit Papers

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 2018 · 372 citations
3720+5+10Years since publication4008001.2k

Peers

Ranee Mehra
Comparison fields: 5 of 105
  • Otorhinolaryngology 3.4k
  • Oncology 3.8k
  • Pulmonary and Respiratory Medicine 2.3k
  • Cancer Research 462
  • Endocrinology, Diabetes and Metabolism 448
Replace William N. William with:
William N. William United States
José Manuel Trigo Spain
Renato G Martins United States
Mark Agulnik United States
Federica Perrone Italy
Nadia Amellal France
Juan José Zarbá United States
Herbert Ho-Fung Loong Hong Kong
Bogusława Karaszewska Poland
Özgür Özyılkan Türkiye
Ranee Mehra relative to William N. William United States William N. William's profile →
Citations per field
00.5×1.5×2×2.4×
William N. William · 1×
Citations per year

Countries citing papers authored by Ranee Mehra

Since Specialization
Citations

This map shows the geographic impact of Ranee Mehra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranee Mehra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranee Mehra more than expected).

Fields of papers citing papers by Ranee Mehra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranee Mehra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranee Mehra. The network helps show where Ranee Mehra may publish in the future.

Co-authors

The 25 scholars most cited alongside Ranee Mehra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ranee Mehra Line = papers co-authored together Ranee Mehra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Hit paper breakdown →
20161449
2
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Hit paper breakdown →
20181385
3
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Hit paper breakdown →
20141251
4
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Hit paper breakdown →
2016720
5
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
Hit paper breakdown →
2011485
6
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Hit paper breakdown →
2014422
7
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Hit paper breakdown →
2016402
8
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Hit paper breakdown →
2018372
9
Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States
Hit paper breakdown →
2015337
10 2018274
11 2019200
12 2015158
13 2017143
14 2014129
15 2012126
16 2017113
17 2017110
18 2018107
19 201592
20 201491

About Ranee Mehra

Ranee Mehra is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 165 papers that have together received 11k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (79 papers), Lung Cancer Treatments and Mutations (26 papers), Cancer Immunotherapy and Biomarkers (23 papers), Cancer Genomics and Diagnostics (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Otorhinolaryngology (3.4k citations), Oncology (3.8k citations), Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (462 citations) and Endocrinology, Diabetes and Metabolism (448 citations). Ranee Mehra has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Barbara Ann Burtness, Laura Q.M. Chow, Jonathan D. Cheng, Tanguy Y. Seiwert, Jared Weiss, Joseph P. Eder, John Andrew Ridge, Jared K. Lunceford, Thomas James Galloway and Terrill K. McClanahan. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Head & Neck, Oral Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact